TY - GEN A1 - Rodríguez Sillke, Yasmina A1 - Schumann, Michael A1 - Lissner, Donata A1 - Branchi, Frederica A1 - Glauben, Rainer A1 - Siegmund, Britta T1 - Small intestinal inflammation but not colitis drives pro-inflammatory nutritional antigen-specific T-cell response T2 - Journal of Crohn's and Colitis N2 - Background: Inflammatory bowel disease (IBD) represents a dysregulation of the mucosal immune system. The pathogenesis of Crohn’s disease (CD) and ulcerative colitis (UC) is linked to the loss of intestinal tolerance and barrier function. The healthy mucosal immune system has previously been shown to be inert against food antigens. Since the small intestine is the main contact surface for antigens and therefore the immunological response, the present study served to analyse food-antigen-specific T cells in the peripheral blood of IBD patients. Methods: Peripheral blood mononuclear cells of CD, with an affected small intestine, and UC (colitis) patients, either active or in remission, were stimulated with the following food antigens: gluten, soybean, peanut and ovalbumin. Healthy controls and celiac disease patients were included as controls. Antigen-activated CD4+ T cells in the peripheral blood were analysed by a magnetic enrichment of CD154+ effector T cells and a cytometric antigen-reactive T-cell analysis (‘ARTE’ technology) followed by characterisation of the ef- fector response. Results: The effector T-cell response of antigen-specific T cells were compared between CD with small intestinal inflammation and UC where inflammation was restricted to the colon. Among all tested food antigens, the highest frequency of antigen-specific T cells (CD4+CD154+) was found for gluten. Celiac disease patients were included as control, since gluten has been identified as the disease- causing antigen. The highest frequency of gluten antigen-specific T cells was revealed in active CD when compared with UC, celiac disease on a gluten-free diet (GFD) and healthy controls. Ovalbuminspecific T cells were almost undetectable, whereas the reaction to soybean and peanut was slightly higher. But again, the strong- est reaction was observed in CD with small intestinal involvement compared with UC. Remarkably, in celiac disease on a GFD only antigen-specific cells for gluten were detected. These gluten-specific T cells were characterised by up-regulation of the pro-inflammatory cytokines IFN-γ, IL-17A and TNF-α. IFN-g was exclusively elevated in CD patients with active disease. Gluten-specific T-cells expressing IL-17A were increased in all IBD patients. Furthermore, T cells of CD patients, independent of disease activity, revealed a high expression of the pro-inflammatory cytokine TNF-α. Conclusion: The ‘ARTE’-technique allows to analyse and quantify food antigen specific T cells in the peripheral blood of IBD patients indicating a potential therapeutic insight. These data provide evidence that small intestinal inflammation in CD is key for the development of a systemic pro-inflammatory effector T-cell response driven by food antigens. Y1 - 2020 U6 - https://doi.org/10.1093/ecco-jcc/jjz203.172 SN - 1873-9946 SN - 1876-4479 VL - 14 SP - S154 EP - S155 PB - Oxford Univ. Press CY - Oxford ER - TY - GEN A1 - Döge, Nadine A1 - Schumacher, Fabian A1 - Balzus, Benjamin A1 - Colombo, Miriam A1 - Hadam, Sabrina A1 - Rancan, Fiorenza A1 - Blume-Peytavi, Ulrike A1 - Kleuser, Burkhard A1 - Bodmeier, Roland A1 - Vogt, Annika T1 - Particle- based formulations and controlled skin barrier disruption have a signifi cant impact on the delivery and penetration kinetics of dexamethasone as assessed in an ex vivo microdialysis T2 - Journal der Deutschen Dermatologischen Gesellschaft N2 - Preclinical assessment of penetration not only in intact, but also in barrier‐disrupted skin is important to explore the surplus value of novel drug delivery systems, which can be specifically designed for diseased skin. Here, we characterized physical and chemical barrier disruption protocols for short‐term ex vivo skin cultures with regard to structural integrity, physiological and biological parameters. Further, we compared the penetration of dexamethasone (Dex) in different nanoparticle‐based formulations in stratum corneum, epidermis and dermis extracts of intact vs. barrier‐disrupted skin as well as by dermal microdialysis at 6, 12 and 24 hours after topical application. Dex was quantified by liquid‐chromatography ‐ tandem‐mass spectrometry (LC‐MS/MS). Simultaneously, we investigated the Dex efficacy by interleukin (IL) analysis. Tape‐stripping (TS) and 4 hours sodium lauryl sulfate 5 % (SLS) exposure were identified as highly effective barrier disruption methods assessed by reproducible transepidermal water loss (TEWL) changes and IL‐6/8 increase which was more pronounced in SLS‐treated skin. The barrier state has also a significant impact on the Dex penetration kinetics: for all formulations, TS highly increased dermal Dex concentration despite the fact that nanocrystals quickly and effectively penetrated both, intact and barrier‐disrupted skin reaching significantly higher dermal Dex concentration after 6 hours compared to Dex cream. The surplus value of encapsulation in ethyl cellulose nanocarriers could mostly be observed when applied on intact skin, in general showing a delayed Dex penetration. Estimation of cytokines was limited due to the trauma caused by probe insertion. In summary, ex vivo human skin is a highly interesting short‐term preclinical model for the analysis of penetration and efficacy of novel drug delivery systems. Y1 - 2017 SN - 1610-0379 SN - 1610-0387 VL - 15 SP - 182 EP - 182 PB - Wiley CY - Berlin ER - TY - GEN A1 - Halibasic, Emina A1 - Fuerst, Elisabeth A1 - Heiden, Denis A1 - Japtok, Lukasz A1 - Diesner, Susanne C. A1 - Hillebrand, P. A1 - Trauner, Michael A1 - Kleuser, Burkhard A1 - Kazemi-Shirazi, Lili A1 - Untersmayr, Eva T1 - Significantly reduced plasma levels of the bioactive sphingolipid S1P in lung transplanted cystic fibrosis patients are associated with gastrointestinal symptoms T2 - Allergy Y1 - 2017 SN - 0105-4538 SN - 1398-9995 VL - 72 IS - S103 SP - 195 EP - 195 PB - Wiley CY - Hoboken ER - TY - GEN A1 - Chen, Pan A1 - Bornhorst, Julia A1 - Neely, M. Diana A1 - Avila, Daiana Silva T1 - Mechanisms and Disease Pathogenesis Underlying Metal-Induced Oxidative Stress T2 - Oxidative Medicine and Cellular Longevity Y1 - 2018 U6 - https://doi.org/10.1155/2018/7612172 SN - 1942-0900 SN - 1942-0994 PB - Hindawi CY - London ER - TY - GEN A1 - Steinberg, Pablo T1 - Only one Component of a holistic Nutrition Policy T1 - Nur ein Baustein einer ganzheitlichen Ernährungspolitik T2 - Fleischwirtschaft Y1 - 2018 SN - 0015-363X VL - 98 IS - 11 SP - 8 EP - 9 PB - Deutscher Fachverlag GmbH CY - Frankfurt am Main ER - TY - GEN A1 - Hocher, Berthold A1 - Zeng, Shufei T1 - Need for better PTH assays for clinical research and patient treatment T2 - Clinical chemistry and laboratory medicine : journal of the Forum of the European Societies of Clinical Chemistry - the European Branch of the International Federation of Clinical Chemistry and Laboratory Medicine Y1 - 2017 U6 - https://doi.org/10.1515/cclm-2017-0617 SN - 1434-6621 SN - 1437-4331 VL - 56 IS - 2 SP - 183 EP - 185 PB - De Gruyter CY - Berlin ER - TY - GEN A1 - Pischon, Hannah A1 - Radbruch, Moritz A1 - Ostrowski, Anja A1 - Schumacher, Fabian A1 - Hoenzke, Stefan A1 - Kleuser, Burkhard A1 - Hedtrich, Sarah A1 - Fluhr, Joachim W. A1 - Gruber, Achim D. A1 - Mundhenk, Lars T1 - How Effective Is Tacrolimus in the Imiquimod BT - Induced Mouse Model of Psoriasis? T2 - The journal of investigative dermatology Y1 - 2017 U6 - https://doi.org/10.1016/j.jid.2017.09.019 SN - 0022-202X SN - 1523-1747 VL - 138 IS - 2 SP - 455 EP - 458 PB - Elsevier CY - New York ER - TY - GEN A1 - Honnen, S. A1 - Wellenberg, Anna A1 - Weides, L. A1 - Bornhorst, Julia A1 - Crone, B. A1 - Karst, U. A1 - Fritz, G. T1 - Identification of potent drug candidates for the prevention of cisplatin-induced neurotoxicity in the model organism C. elegans T2 - Naunyn-Schmiedeberg's archives of pharmacology Y1 - 2018 UR - https://link.springer.com/content/pdf/10.1007/s00210-018-1477-5.pdf U6 - https://doi.org/10.1007/s00210-018-1477-5 SN - 0028-1298 SN - 1432-1912 VL - 391 SP - S4 EP - S4 PB - Springer CY - New York ER - TY - GEN A1 - Reichetzeder, Christoph A1 - Hocher, Berthold T1 - DPP4 inhibition prevents AKI T2 - Oncotarget KW - acute kidney injury KW - DPP-4 inhibitors KW - ischemia reperfusion injury KW - gliptins KW - Dipeptidyl peptidase IV Y1 - 2017 U6 - https://doi.org/10.18632/oncotarget.20212 SN - 1949-2553 VL - 8 SP - 64655 EP - 64656 PB - Impact Journals LLC CY - Orchard Park ER - TY - GEN A1 - Hocher, Berthold A1 - Zeng, Shufei T1 - Clear the fog around parathyroid hormone assays BT - what do iPTH assays really measure? T2 - Clinical journal of the American Society of Nephrology KW - Assays KW - Biological Assay KW - CKD KW - oxidative stress KW - PTH Y1 - 2018 U6 - https://doi.org/10.2215/CJN.01730218 SN - 1555-9041 SN - 1555-905X VL - 13 IS - 4 SP - 524 EP - 526 PB - American Society of Nephrology CY - Washington ER - TY - GEN A1 - Fernando, Raquel A1 - Drescher, Cathleen A1 - Deubel, Stefanie A1 - Grune, Tilman A1 - Castro, Jose Pedro T1 - Distinct proteasomal activity for fast and slow twitch skeletal muscle during aging T2 - Free radical biology and medicine : the official journal of the Oxygen Society, a constituent member of the International Society for Free Radical Research N2 - Skeletal muscle alterations during aging lead to dysfunctional metabolism, correlating with frailty and early mortality. The loss of proteostasis is a hallmark of aging. Whether proteostasis loss plays a role in muscle aging remains elusive. To address this question we collected muscles, Soleus (SOL, type I) and Extensor digitorum longus (EDL, type II), from young (4 months) and old (25 months) C57BL/6 mice and evaluated the proteasomal system. Initial work showed decreased 26 S activity in old SOL. EDL displayed lower proteasomal activity in both ages compared to any of the SOL ages. Moreover, in order to understand if during aging there is the so-called “fiber switch from fast-to-slow”, we performed western blots against sMHC and fMHC (slow and fast myosin heavy chain, respectively). Preliminary results suggest that young SOL is composed by slow twitch fibers but also contains fast twitch fibers, while young EDL seems to be mostly composed by fast twitch fibers that level down during aging, suggesting the switch. As a conclusion, EDL seems to have less proteasomal activity, however, if this is a contributor or a consequence to the muscle fiber switch during aging still needs further investigation. Y1 - 2018 U6 - https://doi.org/10.1016/j.freeradbiomed.2018.04.393 SN - 0891-5849 SN - 1873-4596 VL - 120 SP - S119 EP - S119 PB - Elsevier CY - New York ER - TY - GEN A1 - Schulze, Matthias B. A1 - Martinez-Gonzalez, Miguel A. A1 - Fung, Teresa T. A1 - Lichtenstein, Alice H. A1 - Forouhi, Nita G. T1 - Food based dietary patterns and chronic disease prevention T2 - BMJ-British medical journal N2 - Matthias B Schulze and colleagues discuss current knowledge on the associations between dietary patterns and cancer, coronary heart disease, stroke, and type 2 diabetes, focusing on areas of uncertainty and future research directions. Y1 - 2018 U6 - https://doi.org/10.1136/bmj.k2396 SN - 1756-1833 VL - 361 PB - BMJ Publishing Group CY - London ER - TY - GEN A1 - Jamnok, Jutatip A1 - Sanchaisuriya, Kanokwan A1 - Yamsri, Supawadee A1 - Fucharoen, Goonnapa A1 - Fucharoen, Supan A1 - Schweigert, Florian J. A1 - Sanchaisuriya, Pattara T1 - Application of a new portable nephelometer for screening thalassemia in countries with limited resources T2 - International Journal of Laboratory Hematology Y1 - 2018 SN - 1751-5521 SN - 1751-553X VL - 40 SP - 62 EP - 62 PB - Wiley CY - Hoboken ER - TY - GEN A1 - Jamnok, Jutatip A1 - Sanchaisuriya, Kanokwan A1 - Yamsri, Supawadee A1 - Fucharoen, Goonnapa A1 - Fucharoen, Supan A1 - Schweigert, Florian J. A1 - Sanchaisuriya, Pattara T1 - Application of a new portable nephelometer for screening thalassemia in countries with limited resources T2 - International journal of laboratory hematology N2 - One-tube osmotic fragility (OF) test is a rapid test used widely for screening thalassemia in countries with limited resources. The test has important limitation in that its accuracy relies on observers’ experience. The iCheck Turbidity is a prototype of portable nephelometer developed by BioAnalyt (Bioanalyt GmbH, Germany). In this study, we assessed the applicability of the iCheck Turbidity, for checking turbidity of the OF-test Y1 - 2018 SN - 1751-5521 SN - 1751-553X VL - 40 SP - 62 EP - 62 PB - Wiley CY - Hoboken ER - TY - GEN A1 - Kleuser, Burkhard T1 - The enigma of sphingolipids in health and disease T2 - International journal of molecular sciences Y1 - 2018 U6 - https://doi.org/10.3390/ijms19103126 SN - 1422-0067 VL - 19 IS - 10 PB - MDPI CY - Basel ER - TY - GEN A1 - Henze, Andrea T1 - Proteinoxidation als Indikator des Alterungsphänotyps und Target einer individualisierten Ernährungsintervention (ProAID) T1 - Protein Oxidation as an Indicator of the Aging Phenotype and Target of an individualized Nutritional Intervention (ProAID) T2 - Ernährungs-Umschau : Forschung & Praxis N2 - Oxidative posttranslationale Modifikationen endogener Proteine werden v. a. durch reaktive Sauerstoff- und Stickstoffspezies (engl:. Reactive Oxygen Species, ROS, reactive nitrogen species, RNS) hervorgerufen und können sowohl reversibel (z. B. Disulfidbindungen) als auch irreversibel (z. B. Proteincarbonyle) erfolgen [1–3]. Lange wurde angenommen, dass oxidative posttranslationale Proteinmodifikationen (oxPTPM) nur von untergeordneter Bedeutung für den Metabolismus sind. Tatsächlich handelt es sich jedoch um einen physiologischen Prozess, der über die Modulation der Proteinstruktur auch die Proteinfunktion (z. B. Enzymaktivität, Stabilität) und somit zahlreiche Stoffwechselwege wie den Energiestoffwechsel, die Immunfunktion, die vaskuläre Funktion sowie Apoptose und Genexpression beeinflussen kann. Die Bildung von oxPTPM ist dabei hochreguliert und hängt u. a. von der Proteinstruktur, der Verfügbarkeit von ROS und RNS sowie dem lokalen Mikromilieu der Zelle ab [2, 4]. Y1 - 2018 SN - 0174-0008 VL - 65 IS - 10 SP - M566 EP - M567 PB - Umschau-Zeitschriftenverl. CY - Frankfurt, Main ER - TY - GEN A1 - Uhlig, Katja A1 - Gehre, Christian P. A1 - Kammerer, Sarah A1 - Küpper, Jan-Heiner A1 - Coleman, Charles Dominic A1 - Püschel, Gerhard Paul A1 - Duschl, Claus T1 - Real-time monitoring of oxygen consumption of hepatocytes in a microbioreactor T2 - Toxicology letters Y1 - 2018 U6 - https://doi.org/10.1016/j.toxlet.2018.06.652 SN - 0378-4274 SN - 1879-3169 VL - 295 SP - S115 EP - S115 PB - Elsevier CY - Clare ER - TY - GEN A1 - Ponce, Carol Barahona A1 - Scherer, Dominique A1 - Boekstegers, Felix A1 - Garate-Calderon, Valentina A1 - Jenab, Mazda A1 - Aleksandrova, Krasimira A1 - Katzke, Verena A1 - Weiderpass, Elisabete A1 - Bonet, Catalina A1 - Moradi, Tahereh A1 - Fischer, Krista A1 - Bossers, Willem A1 - Brenner, Hermann A1 - Schöttker, Ben A1 - Holleczek, Bernd A1 - Hveem, Kristian A1 - Eklund, Niina A1 - Voelker, Uwe A1 - Waldenberger, Melanie A1 - Bermejo, Justo Lorenzo T1 - Arsenic and gallbladder cancer risk BT - Mendelian randomization analysis of European prospective data T2 - International journal of cancer KW - arsenic KW - gallbladder cancer KW - Mendelian randomization Y1 - 2019 U6 - https://doi.org/10.1002/ijc.32837 SN - 0020-7136 SN - 1097-0215 VL - 146 IS - 9 SP - 2648 EP - 2650 PB - Wiley CY - Hoboken ER - TY - GEN A1 - Wellenberg, Anna A1 - Weides, L. A1 - Bornhorst, Julia A1 - Crone, Barbara A1 - Karst, U. A1 - Fritz, G. A1 - Honnen, S. T1 - Molecular and electrophysiological analysis of platinum-induced neurotoxicity using the model organism C. elegans T2 - Naunyn-Schmiedeberg's archives of pharmacology Y1 - 2019 UR - https://link.springer.com/content/pdf/10.1007%2Fs00210-019-01621-6.pdf U6 - https://doi.org/10.1007/s00210-019-01621-6 SN - 0028-1298 SN - 1432-1912 VL - 392 SP - S63 EP - S63 PB - Springer CY - New York ER - TY - GEN A1 - Kleuser, Burkhard T1 - Medikamentennebenwirkungen auf Haut und Schleimhaut – allergische oder pharmakologisch erklärbare Reaktionen T2 - Allergologie T2 - Side Effects on Skin and Mucous Membrane - allergic or pharmacologically explainable Reactions Y1 - 2017 SN - 0344-5062 VL - 40 IS - 10 SP - 420 EP - 421 PB - Dustri-Verlag CY - Deisenhofen-München ER - TY - GEN A1 - Plank, Roswitha A1 - Yealland, Guy A1 - Miceli, Enrico A1 - Cunha, Dulce Lima A1 - Graff, Patrick A1 - Thomforde, Sari A1 - Gruber, Robert A1 - Moosbrugger-Martinz, Verena A1 - Eckl, Katja A1 - Calderon, Marcelo A1 - Hennies, Hans Christian A1 - Hedtrich, Sarah T1 - Transglutaminase 1 Replacement Therapy Successfully Mitigates the Autosomal Recessive Congenital Ichthyosis Phenotype in Full-Thickness Skin Disease Equivalents T2 - The journal of investigative dermatology Y1 - 2019 U6 - https://doi.org/10.1016/j.jid.2018.11.002 SN - 0022-202X SN - 1523-1747 VL - 139 IS - 5 SP - 1191 EP - 1195 PB - Elsevier CY - New York ER - TY - GEN A1 - Hocher, Berthold A1 - Tsuprykov, Oleg T1 - Renoprotective effects of GLP1R agonists and SGLT2 inhibitors T2 - Nature reviews nephroloy N2 - New data from the LEADER trial show that the glucagon-like peptide 1 receptor agonist liraglutide protects against diabetic nephropathy in patients with type 2 diabetes mellitus. The renoprotective efficacy of liraglutide is not, however, as great as that reported for the sodium-glucose cotransporter 2 inhibitor emplagiflozin in the EMPA-REG OUTCOME trial. Y1 - 2017 U6 - https://doi.org/10.1038/nrneph.2017.140 SN - 1759-5061 SN - 1759-507X VL - 13 SP - 728 EP - 729 PB - Nature Publ. Group CY - New York ER - TY - GEN A1 - Zeiher, Johannes A1 - Duch, M. A1 - Kroll, Lars Eric A1 - Mensink, Gerhardus Bernardus Maria A1 - Finger, Jonas David A1 - Keil, Thomas T1 - Domain-specific physical activity patterns and cardiorespiratory fitness among adults in Germany T2 - The European Journal of Public Health N2 - Background Studies show that occupational physical activity (OPA) has less health-enhancing effects than leisure-time physical activity (LTPA). The spare data available suggests that OPA rarely includes aerobic PAs with little or no enhancing effects on cardiorespiratory fitness (CRF) as a possible explanation. This study aims to investigate the associations between patterns of OPA and LTPA and CRF among adults in Germany. Methods 1,204 men and 1,303 women (18-64 years), who participated in the German Health Interview and Examination Survey 2008-2011, completed a standardized sub-maximal cycle ergometer test to estimate maximal oxygen consumption (VO2max). Job positions were coded according to the level of physical effort to construct an occupational PA index and categorized as low vs. high OPA. LTPA was assessed via questionnaires and dichotomized in no vs. any LTPA participation. A combined LTPA/OPA variable was used (high OPA/ LTPA, low OPA/LTPA, high OPA/no LTPA, low OPA/no LTPA). Information on potential confounders was obtained via questionnaires (e.g., smoking and education) or physical measurements (e.g., waist circumference). Multi-variable logistic regression was used to analyze associations between OPA/LTPA patterns and VO2max. Results Preliminary analyses showed that less-active men were more likely to have a low VO2max with odds ratios (ORs) of 0.80 for low OPA/LTPA, 1.84 for high OPA/no LTPA and 3.46 for low OPA/no LTPA compared to high OPA/LTPA. The corresponding ORs for women were 1.11 for low OPA/LTPA, 3.99 for high OPA/no LTPA and 2.44 for low OPA/no LTPA, indicating the highest likelihood of low fitness for women working in physically demanding jobs and not engaging in LTPA. Conclusions Findings confirm a strong association between LTPA and CRF and suggest an interaction between OPA and LTPA patterns on CRF within the workforce in Germany. Women without LTPA are at high risk of having a low CRF, especially if they work in physically demanding jobs. Key messages Women not practicing leisure-time physical activity are at risk of having a low cardiorespiratory fitness, especially if they work in physically demanding jobs. Different impact of domains of physical activity should be considered when planning interventions to enhance fitness among the adult population. Y1 - 2019 SN - 1101-1262 SN - 1464-360X VL - 29 IS - Supplement. 4 PB - Oxford Univ. Press CY - Oxford ER - TY - GEN A1 - Doege, N. A1 - Hoenzke, S. A1 - Schumacher, Fabian A1 - Balzus, Benjamin A1 - Colombo, Miriam A1 - Hadam, S. A1 - Rancan, F. A1 - Blume-Peytavi, Ulrike A1 - Schindler, A. A1 - Ruehl, E. A1 - Skov, P. A1 - Church, Martin K. A1 - Hedtrich, Sarah A1 - Kleuser, Burkhard A1 - Bodmeier, Roland A1 - Vogt, A. T1 - Ex vivo microdialysis used for the preclinical assessment of anti-inflammatory therapy T2 - Experimental dermatology : the official journal of the European Immunodermatology Society Y1 - 2016 SN - 0906-6705 SN - 1600-0625 VL - 25 SP - E32 EP - E32 PB - Wiley-Blackwell CY - Hoboken ER - TY - GEN A1 - Bijleveld, Catrien A1 - Zoutewelle-Terovan, Mioara A1 - Huschek, Doreen A1 - Liefbroer, Aart C. T1 - Criminal careers and demographic outcomes: An introduction to the special issue T2 - Advances in life course research Y1 - 2016 U6 - https://doi.org/10.1016/j.alcr.2016.05.001 SN - 1569-4909 SN - 1879-6974 VL - 28 SP - 1 EP - 5 PB - Elsevier CY - Oxford ER - TY - GEN A1 - Hollmann, C. A1 - Reuter, D. A1 - Werner, S. A1 - Avota, Elita A1 - Mueller, N. A1 - Japtok, Lukasz A1 - Kleuser, Burkhard A1 - Becker, Katrin Anne A1 - Gulbins, Erich A1 - Schneider-Schaulies, Jürgen A1 - Beyersdorf, Niklas T1 - Pharmacological inhibition of acid sphingomyelinase or genetic ablation enhances CD4(+) Foxp3(+) regulatory T cell activity T2 - European journal of immunology Y1 - 2016 SN - 0014-2980 SN - 1521-4141 VL - 46 SP - 14 EP - 14 PB - Wiley-Blackwell CY - Hoboken ER - TY - GEN A1 - Schernthaner, G. A1 - Groop, P. A1 - Cooper, M. A1 - Perkovic, V A1 - Hocher, Berthold A1 - Kanasaki, K. A1 - Sharma, K. A1 - Stanton, R. A1 - Toto, R. A1 - Cescutti, Jessica A1 - Gordat, M. A1 - Meinicke, T. A1 - Koitka-Weber, A. A1 - Woerle, H. A1 - Eynatten, M. T1 - EFFECTS OF LINAGLIPTIN ON GLYCAEMIC CONTROL AND ALBUMINURIA IN TYPE 2 DIABETES - THE MARLINA-T2D (TM) TRIAL T2 - Nephrology Y1 - 2016 U6 - https://doi.org/10.1111/nep.12887 SN - 1320-5358 SN - 1440-1797 VL - 21 SP - 60 EP - 60 PB - Wiley-Blackwell CY - Hoboken ER - TY - GEN A1 - Nojima, Hiroyuki A1 - Konishi, Takanori A1 - Japtok, Lukasz A1 - Kleuser, Burkhard A1 - Edwards, Michael J. A1 - Gulbins, Erich A1 - Lentsch, Alex B. T1 - Chemokine receptors, CXCR1 and CXCR2, differentially regulate exosome release in hepatocytes T2 - Hepatology : official journal of the American Association for the Study of Liver Diseases Y1 - 2016 SN - 0270-9139 SN - 1527-3350 VL - 64 SP - 165A EP - 165A PB - Wiley-Blackwell CY - Hoboken ER - TY - GEN A1 - Bäumer, Wolfgang A1 - Rossbach, Kristine A1 - Mischke, Reinhard A1 - Reines, Ilka A1 - Langbein-Detsch, Ines A1 - Lüth, Anja A1 - Kleuser, Burkhard T1 - Decreased concentration and enhanced metabolism of sphingosine-1-Phosphate in lesional skin of dogs with atopic dermatitis disturbed Sphingosine-1-Phosphate homeostasis in atopic Dermatitis T2 - The journal of investigative dermatology Y1 - 2011 U6 - https://doi.org/10.1038/jid.2010.252 SN - 0022-202X VL - 131 IS - 1 SP - 266 EP - 268 PB - Nature Publ. Group CY - New York ER - TY - GEN A1 - Polzin, Amin A1 - Rassaf, Tienush A1 - Boehm, Andreas A1 - Lueth, Anja A1 - Kleuser, Burkhard A1 - Zeus, Tobias A1 - Kelm, Malte A1 - Kroemer, Heyo K. A1 - Schroer, Karsten A1 - Rauch, Bernhard H. T1 - Aspirin inhibits release of platelet-derived sphingosine-1-phosphate in acute myocardial infarction T2 - INTERNATIONAL JOURNAL OF CARDIOLOGY KW - Sphingosine-1-phosphate KW - Acute coronary syndrome KW - Platelets KW - Aspirin Y1 - 2013 U6 - https://doi.org/10.1016/j.ijcard.2013.10.050 SN - 0167-5273 SN - 1874-1754 VL - 170 IS - 2 SP - E23 EP - E24 PB - ELSEVIER IRELAND LTD CY - CLARE ER - TY - GEN A1 - Mazurek, Nicole T1 - Untersuchungen zur Genexpression und Differenzierung muriner embryonaler Stammzellen in vitro zur Prädiktion eines embryotoxischen Potentials ausgewählter Chemikalien T1 - Investigations for gene expression and differentiation of murine embryonic stem cells in vitro to predict the embryotoxic potential of selected chemicals N2 - Der Embryonale Stammzelltest (EST) ist ein validierter In-vitro-Embryotoxizitätstest, der zur Untersuchung embryotoxischer Wirkungen von Chemikalien eingesetzt werden kann. Während des zehntägigen Differenzierungsassays differenzieren sich die pluripotenten murinen embryonalen Stammzellen (ES-Zellen) der Linie D3 in vitro in spontan kontrahierende Herzmuskelzellen. Dabei rekapitulieren sie Prozesse der frühen Embryogenese in vivo. Ein Zytotoxizitätsassay mit D3-Zellen und ausdifferenzierten, adulten 3T3-Maus-Fibroblasten dient der Ermittlung allgemeiner zytotoxischer Effekte und unterschiedlicher Sensitivitäten beider Zelllinien. Somit basiert der EST auf den beiden wichtigsten Mechanismen pränataler Toxizität, der Störung der Differenzierung und der Zytotoxizität. Ziel dieser Arbeit war es, mit Hilfe des EST das embryotoxische Potential der vier Chemikalien Trichostatin A (TSA), Methylazoxymethanolacetat (MAMac), Natriumdodecylsulfat (SDS) und Benzoesäure (BA) abzuschätzen. Dazu wurde mikroskopisch ermittelt, bei welcher Testsubstanzkonzentration in 50 % der während der In-vitro-Differenzierung gebildeten Embryonalkörperchen die Kardiomyozytendifferenzierung inhibiert wird (ID50). Außerdem wurde die halbmaximale Hemmkonzentration des Zellwachstums auf die beiden Zelllinien bestimmt (IC50D3 bzw. IC503T3). Als Erweiterung dieses konventionellen EST wurden mittels quantitativer Real Time-PCR an den Tagen 5, 7 und 10 der Differenzierung zusätzlich Genexpressionsanalysen etablierter herzmuskelspezifischer Markergene (Mesoderm Posterior 1, Tag 5; Myosin light chain 1, Tag 7 und 10) durchgeführt. Deren Expression korreliert in den ES-Zellen mit der embryonalen Herzdifferenzierung in vivo und kann zur Ermittlung der von der Prüfsubstanz hervorgerufenen halbmaximalen Hemmung der Genexpression in den Kardiomyozyten (IC50 Exp) herangezogen werden. Um letztlich embryotoxische Effekte in vivo auf Grundlage der ermittelten In-vitro-Daten abschätzen zu können, wurden die ermittelten Parameter mittels eines für den EST empirisch abgeleiteten mathematischen Prädiktionsmodells (PM) zur Klassifizierung der Testsubstanzen als nicht, schwach oder stark embryotoxisch herangezogen. Für jede der Substanzen waren die ermittelten Halbhemmkonzentrationen in den überwiegenden Fällen vergleichbar und führten unter Verwendung des PMs im konventionellen und im molekularen EST zu deren identischer Klassifizierung. TSA wurde als „stark embryotoxisch“ klassifiziert und beeinflusste insbesondere das Differenzierungspotential der ES-Zellen. Das als „schwach embryotoxisch“ klassifizierte SDS wirkte auf die D3-Zellen stärker differenzierungsinhibierend als zytotoxisch, hemmte jedoch das Wachstum der 3T3-Zellen bereits in deutlich niedrigeren Konzentrationen. MAMac und BA wurden als „nicht embryotoxisch“ klassifiziert. Bei ihnen stand die zytotoxische Wirkung deutlich im Vordergrund. Diese Prädiktionen stimmten mit In-vivo-Befunden überein, was von der Stabilität und der Brauchbarkeit der im konventionellen und molekularen EST ermittelten Parameter zeugte. Einzige Ausnahme war das als Entwicklungsneurotoxin in vivo bekannte MAMac. Da der EST auf mesodermaler Differenzierung basiert, können spezifische Effekte auf neuronale Entwicklungsprozesse offenbar nicht vollständig erfasst werden. Substanzkonzentrationen, die sich als differenzierungsinhibierend auf die morphologische Kardiomyozytendifferenzierung erwiesen haben, führten auch zu einer messbaren Repression der herzmuskelspezifischen Genexpression. Dabei erwies sich die IC50 Exp als ebenso sensitiv wie die konventionellen Parameter und als nutzbringende Ergänzung zu diesen, da sie bereits nach 5 bzw. 7 Tagen der In-vitro-Differenzierung eine mit dem mikroskopischen Parameter übereinstimmende Einschätzung des embryotoxischen Potentials der Chemikalien in vivo ermöglichte. Genexpressionsanalysen weiterer differenzierungsspezifischer Gene können zusätzlich zur Aufklärung zu Grunde liegender Mechanismen der Embryotoxizität von Testsubstanzen dienen. Somit kann der EST durch die Vorteile der Stammzelltechnologie und der Genexpressionsanalyse als neues prädiktives Screening-Instrument zur frühzeitigen Detektion embryotoxischer Substanzeffekte in der pharmazeutischen und chemischen Industrie genutzt werden. N2 - The embryonic stem cell test (EST) represents a validated in vitro embryotoxicity test that can be utilised for investigations of embryotoxic effects of chemical substances. During the 10-day differentiation assay the pluripotent murine embryonic stem cells (ES cells) of the D3 line differentiate in vitro into spontaneously beating cardiac muscle cells that can be observed microscopically. Thereby, ES cells recapitulate processes of early embryogenesis in vivo. A cytotoxicity assay with D3 cells as well as differentiated, adult 3T3 mouse fibroblasts is used to determine general cytotoxic effects and to consider differences in the sensitivity of both cell lines. Hence the EST is based on the two most important mechanisms of prenatal toxicity, such as inhibition of differentiation and cytotoxicity. The aim of the presented work consisted in the evaluation of the embryotoxic potential of the four chemicals trichostatin A (TSA), methylazoxymethanolacetate (MAMac), sodium dodecyl sulfate (SDS) and benzoic acid (BA) by means of the EST. For this purpose the concentration of the test substance that causes an inhibition of cardiomyocyte differentiation in 50 % of the embryoid bodies which are formed during the in vitro differentiation (ID50-value) and the halfmaximal inhibiting concentration of cell proliferation of D3 and 3T3 cell lines (IC50D3 and IC503T3) were determined. As extension of this conventional EST, the effect of test substances was investigated at the molecular level by gene expression analyses of cardiac specific genes (Mesoderm Posterior 1, day 5; Myosin light chain 1, day 7 and 10). Their expression in ES cells correlates with the embryonic heart differentiation in vivo. Quantitative Real Time-PCR gene expression analysis was used to determine the halfmaximal inhibition of the cardiomyocyte gene expression (IC50 Exp) caused by the test compound. To predict embryotoxic effects in vivo from the determined in vitro data, these parameters were used for the classification of the test chemicals as non, weak or strong embryotoxic via a mathematical prediction model (PM). In the majority of cases comparable halfmaximal inhibiting concentrations were calculated in the conventional and molecular EST that resulted in the identical classification of the tested chemicals concerning their embryotoxic potential. TSA was estimated as “strongly embryotoxic” and affected particularly the differentiation potential of the ES cells. SDS was classified as “weakly embryotoxic” and acted by inhibiting the differentiation of D3 cells at concentrations lower than cytotoxic concentrations but already repressed the growth of the 3T3 cells in significantly lower ranges. As to MAMac and BA that were classified as “non-embryotoxic” the cytotoxic effects on both cell lines predominated. These predictions were consistent with in vivo findings that testifies the stability and the usefulness of the parameters used in the conventional and molecular EST. MAMac, which is known as a developmental neurotoxin in vivo, represented the single exception. Its misclassification as compared to in vivo data may originate from the limitations of the model system that is based on mesodermal differentiation. Thus, specific effects on neuronal developmental processes obviously cannot be detected completely. Gene expression analysis showed that test substance concentrations which were proved to be inhibiting on the morphological differentiation of cardiomyocytes caused a repression of cardiac-specific marker gene expression as well. Thereby, IC50 Exp-values proved to be just as sensitive as the conventional parameters and can provide valuable and supportive data. They allowed a prediction of the embryotoxic potential of the chemicals in vivo already at day 5 and day 7 of in vitro differentiation. Moreover, gene expression analysis of appropriate differentiation specific genes could be used to investigate mechanisms that are responsible for embryotoxic properties of the test compounds. Thus, the EST is considered to represent a new, predictive screening test especially in the pharmaceutical industry to detect the embryotoxic potential of chemical compounds early in the process of compound development. KW - Embryonaler Stammzelltest (EST) KW - D3-Zellen KW - Differenzierungsassay KW - Zytotoxizitätsassay KW - Genexpressionsanalysen (qRT-PCR) KW - embryonic stem cell test (EST) KW - D3 cells KW - differentiation assay KW - cytotoxicity assay KW - gene expression analysis (qRT-PCR) Y1 - 2007 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:kobv:517-opus-68912 ER -